IOVA

2.27

4.13% 0.09

Dopo l'orario di chiusura: 2.30 0.03 +1.32%

Iovance Biotherapeutics Inc (IOVA)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché IOVA Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$2.18

Aprire:

$2.2

Volume 24 ore:

15.13M

Relative Volume:

1.02

Capitalizzazione di mercato:

$821.41M

Reddito:

$241.53M

Utile/perdita netta:

$-389.92M

Rapporto P/E:

-1.8455

EPS:

-1.23

Flusso di cassa netto:

$-323.54M

1 W Prestazione:

+2.71%

1M Prestazione:

-4.62%

6M Prestazione:

-20.35%

1 anno Prestazione:

-76.65%

Intervallo 1D:

$2.18

$2.34

Intervallo di 1 settimana:

$2.09

$2.38

Portata 52W:

$1.6385

$12.51

Iovance Biotherapeutics Inc Stock (IOVA) Company Profile

Nome

Iovance Biotherapeutics Inc

Settore

Healthcare (1141)

Industria

Biotechnology (639)

Telefono

(650) 260-7120

Indirizzo

825 INDUSTRIAL ROAD, SAN CARLOS

Dipendente

838

Cinguettio

Prossima data di guadagno

2024-11-07

Ultimi documenti SEC

IOVA's Discussions on Twitter

Confronta IOVA con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
IOVA Iovance Biotherapeutics Inc	2.27	788.84M	241.53M	-389.92M	-323.54M	-1.23
VRTX Vertex Pharmaceuticals Inc	421.15	105.19B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	450.68	60.24B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	563.86	61.82B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	798.94	49.09B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	351.09	37.52B	4.56B	-176.77M	225.30M	-1.7177

Iovance Biotherapeutics Inc Stock (IOVA) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-07-15	Downgrade	Goldman	Neutral → Sell
2025-05-16	Downgrade	UBS	Buy → Neutral
2025-05-12	Downgrade	Truist	Buy → Hold
2025-05-09	Downgrade	Citizens JMP	Mkt Outperform → Mkt Perform
2024-10-24	Iniziato	UBS	Buy
2024-07-29	Downgrade	Piper Sandler	Overweight → Neutral
2023-11-20	Iniziato	Goldman	Buy
2023-09-18	Reiterato	Barclays	Overweight
2023-05-30	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2023-03-27	Ripresa	Wells Fargo	Equal Weight
2023-01-27	Aggiornamento	Piper Sandler	Neutral → Overweight
2022-12-09	Downgrade	Goldman	Buy → Neutral
2022-10-31	Iniziato	Guggenheim	Neutral
2022-08-18	Ripresa	Wells Fargo	Equal Weight
2022-01-28	Aggiornamento	Stifel	Hold → Buy
2021-12-07	Ripresa	Cowen	Outperform
2021-06-10	Aggiornamento	JMP Securities	Mkt Perform → Mkt Outperform
2021-05-20	Downgrade	Piper Sandler	Overweight → Neutral
2021-05-19	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
2021-05-19	Downgrade	Stifel	Buy → Hold
2021-05-03	Iniziato	Truist	Buy
2021-04-16	Iniziato	Goldman	Buy
2021-03-08	Aggiornamento	H.C. Wainwright	Neutral → Buy
2020-12-15	Downgrade	H.C. Wainwright	Buy → Neutral
2020-10-06	Downgrade	Wells Fargo	Overweight → Equal Weight
2020-04-22	Iniziato	Mizuho	Buy
2020-03-04	Iniziato	Barclays	Overweight
2020-02-26	Reiterato	H.C. Wainwright	Buy
2020-02-26	Reiterato	Oppenheimer	Outperform
2019-12-18	Iniziato	JMP Securities	Mkt Outperform
2019-10-01	Iniziato	Stifel	Buy
2019-04-29	Iniziato	Piper Jaffray	Overweight
2019-02-28	Reiterato	Chardan Capital Markets	Buy
2019-02-07	Iniziato	Robert W. Baird	Outperform
2018-12-31	Ripresa	B. Riley FBR	Buy
2018-07-06	Reiterato	Chardan Capital Markets	Buy
2018-04-10	Aggiornamento	B. Riley FBR, Inc.	Neutral → Buy
2018-03-13	Reiterato	B. Riley FBR, Inc.	Neutral
2018-02-23	Downgrade	B. Riley FBR, Inc.	Buy → Neutral
2018-01-25	Reiterato	H.C. Wainwright	Buy
2017-11-01	Reiterato	B. Riley FBR, Inc.	Buy

Mostra tutto

Iovance Biotherapeutics Inc Borsa (IOVA) Ultime notizie

03:08 AM

IOVANCE (IOVA) ALERT: Bragar Eagel & Squire, P.C. Continues - GlobeNewswire

03:08 AM

01:15 AM

Iovance Biotherapeutics (NASDAQ:IOVA) Trading Up 6.7%What's Next? - MarketBeat

01:15 AM

Oct 06, 2025

Iovance Biotherapeutics (NASDAQ:IOVA) Stock Price Down 4.5%Should You Sell? - MarketBeat

Oct 06, 2025

Iovance Biotherapeutics (IOVA): Examining Valuation as Share Price Momentum Stalls - Yahoo Finance

Oct 06, 2025

How supply shortages influence Iovance Biotherapeutics Inc. (2LB) stock2025 Price Momentum & Growth Oriented Trade Recommendations - newser.com

Oct 06, 2025

Will Iovance Biotherapeutics Inc. rebound enough to break evenAnalyst Downgrade & Safe Entry Trade Signal Reports - newser.com

Oct 06, 2025

Why Iovance Biotherapeutics Inc. (2LB) stock fits value portfoliosChart Signals & Verified Technical Signals - newser.com

Oct 06, 2025

Will Iovance Biotherapeutics Inc. (2LB) stock announce special dividendMarket Sentiment Report & Weekly Top Performers Watchlists - newser.com

Oct 06, 2025

Oct 05, 2025

What the Recent 11% Surge Means for Iovance Biotherapeutics Stock in 2025 - Sahm

Oct 05, 2025

Why Iovance Biotherapeutics Inc. (2LB) stock signals breakout potentialJuly 2025 Opening Moves & Pattern Based Trade Signal System - newser.com

Oct 05, 2025

Oct 04, 2025

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Given Consensus Rating of "Hold" by Analysts - MarketBeat

Oct 04, 2025

Oct 03, 2025

Iovance Biotherapeutics (IOVA) Valuation in Focus After Recent Share Price Gains - Sahm

Oct 03, 2025

How Iovance Biotherapeutics Inc. stock performs during Fed tightening cyclesShort Setup & Capital Efficient Trade Techniques - newser.com

Oct 03, 2025

Is Iovance Biotherapeutics Inc. (2LB) stock positioned for digital growth eraMarket Volume Summary & AI Enhanced Trading Alerts - newser.com

Oct 03, 2025

Oct 02, 2025

Analyzing Iovance Biotherapeutics Inc. with multi timeframe chartsJuly 2025 Fed Impact & Technical Buy Zone Confirmations - newser.com

Oct 02, 2025

Oct 01, 2025

Volatility clustering patterns for Iovance Biotherapeutics Inc.Quarterly Market Review & Capital Efficiency Focused Strategies - newser.com

Oct 01, 2025

Sep 30, 2025

Iovance Biotherapeutics Inc Stock Analysis and ForecastBull Market Opportunities & Set Your Capital Stop-Loss Limits Effectively - earlytimes.in

Sep 30, 2025

What analysts say about Iovance Biotherapeutics Inc stockMoving Average Crossovers & High Return Trading Portfolio - earlytimes.in

Sep 30, 2025

Sep 28, 2025

Iovance Biotherapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - 富途牛牛

Sep 28, 2025

Sep 27, 2025

Is Iovance Biotherapeutics Inc 2LB a good long term investmentStock Market Trends & Access Free Tools and Start Investing - Early Times

Sep 27, 2025

Is Iovance Biotherapeutics Inc a good long term investmentCapital Gains Strategies & Free Hedging Tactics for Volatile Markets - Early Times

Sep 27, 2025

Iovance Biotherapeutics Experiences Revision in Stock Evaluation Amid Market Volatility - Markets Mojo

Sep 27, 2025

Sep 26, 2025

Iovance Biotherapeutics (NASDAQ:IOVA) Share Price Passes Below Two Hundred Day Moving AverageWhat's Next? - MarketBeat

Sep 26, 2025

Sep 25, 2025

Healthcare's Convergence Accelerates as Aging Demographics Meet Breakthrough Therapies - Baystreet.ca

Sep 25, 2025

Sep 21, 2025

Assessing Iovance Biotherapeutics (IOVA) Valuation Following Key Strategic Updates and Growth Plans - Sahm

Sep 21, 2025

Revenue Check: Can Iovance Biotherapeutics Inc deliver consistent EPS growthTrade Entry Report & AI Enhanced Execution Alerts - خودرو بانک

Sep 21, 2025

Sep 20, 2025